Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA258440
National Institutes of Health
Grant: R01CA236226
National Institutes of Health
Grant: R01HL140953
National Institutes of Health
Grant: R21 CA263140
National Institutes of Health
Grant: R37CA251165
American Cancer Society
Grant: IRG-19-137-20
National Institute of General Medical Sciences
Grant: P20GM130457
NIGMS NIH HHS
Grant: R01 GM067945
NIDDK NIH HHS
Grant: P30 DK123704
NIH HHS
Grant: S10 OD025126
National Institutes of Health
Grant: 5R01CA236226-04
Novel therapeutic approaches with CDK4/6 inhibitors for melanoma treatment
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
National Institutes of Health
Grant: 5P30CA138313-09
Medical University of South Carolina - Cancer Center Support Grant
National Institutes of Health
Grant: 3P20GM130457-02S1
CDLD Administrative Supplement for Equipment
National Institutes of Health
Grant: 5R21CA263140-02
ER stress pathways regulate T-cell allogeneic and anti-tumor responses
National Institutes of Health
Grant: 5R37CA251165-02
Novel functions of CDK6 in T-cell leukemia progression
National Institutes of Health
Grant: 5R01HL140953-04
Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse
National Institutes of Health
Grant: 5R01CA258440-04
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
Foundation for the National Institutes of Health
Novartis Pharmaceuticals Corporation
Leukemia Research Foundation
Fields of Study
MeSH Terms
Keywords